Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Enigma Diagnostics Announces Successful Evaluation Of The Enigma FL By The UK's Veterinary Laboratories Agency
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory).

Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely In Re-Limited Settings Without Routine Laboratory Monitoring
Gilead Sciences, Inc. (Nasdaq:GILD) highlighted results from a study known as DART (Development of Anti-Retroviral Treatment in Africa), which evaluated the need for routine laboratory monitoring in adults taking antiretroviral therapy in Africa. The DART trial was an open-label, randomized study comparing clinical and laboratory monitoring to clinical monitoring alone for efficacy and toxicity. In this study, 74 percent of patients were on a treatment regimen containing Viread® (tenofovir disoproxil fumarate). At baseline, more than 50 percent of patients had reduced renal function. The results indicated that Viread was well tolerated and that the incidence of renal adverse events was low. DART researchers concluded that renal function test results were similar in both arms of the trial for up to five years, suggesting that routine monitoring of Viread may not be necessary in re-limited settings when using the product as part of a first-line HIV treatment regimen. The results of the study were presented today at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) in Cape Town, South Africa.
News of the day
An Animal Model For Schizophrenia Identifies A Novel Approach For Treating Cognitive Impairments Associated With Schizophrenia
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder. The first generation of studies trying to stimulate NMDA receptors administered large amounts of substances, like glycine or D-serine, which indirectly enhance NMDA receptor function. While there were some positive reports of efficacy, findings across studies were more inconsistent than was hoped.
Oncology

FBI Should Probe Whether 'Systemic Problems' Led To 'Gaps' In Tiller Murder Case, NYT Editorial States

U.S. Attorney General Eric Holder and Congress "should review the killing" of Kansas abortion provider George Tiller "to determine whether there are systemic problems that led to apparent gaps in the FBI"s performance in the case," a New York Times editorial states. According to the Times, Holder "took the prudent step of ordering" the U.S. Marshals Service to "provide security for certain abortion clinics and physicians thought to be at heightened risk," but the government"s response "must not end there."The editorial states that Scott Roeder, the man accused of killing Tiller, has a history of activity related to the antiabortion-rights movement that "should have sparked greater concern" with the FBI, including being suspected in 2000 of "repeatedly gluing shut the doors of an abortion clinic in Kansas City, Kan. -- a federal crime under the 1994 Freedom of Access to Clinic Entrances law." Roeder also was found in possession of "gunpowder and a fuse" when stopped for a traffic violation in 1996, according to the Times. The editorial states, "In the past, Tiller was shot in both arms, and his clinic was bombed and vandalized," but "it seems as if the federal authorities failed to increase security for Dr. Tiller and his offices."The editorial continues, "An armed criminal bent on murder is hard to stop, and we do not blame the FBI for Dr. Tiller"s death." However, "reproductive rights advocates say enforcement of the clinic protection law waned in the Bush years," the editorial says, concluding that Holder "should make sure there is no underlying problem that inhibits efforts to combat intimidation and violence against the dwindling number of legal abortion providers -- and women they help" (New York Times, 6/8). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009